Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

501

HTML

3337

Figures (1-2)

160

Tables (1-4)

134

Sum=4132

Jan 28, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 28, 2006; 12(4): 603-607
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.603

Table 3 Major toxic effects¹ of chemoradiotherapy

Type of toxic effects	Number of patients (%)
Hematologic anemia	4 (12.9)
Neutropenia	15 (50.2)
Thrombocytopenia	1 (3.2)
Nausea/Vomiting	1 (3.2)
Diarrhea	1 (3.2)
Adhesive ileus requiring operation	2 (6.4)

¹ Major toxic effects were defined as those of grade 3/4.

Citation: Lee HS, Choi Y, Hur WJ, Kim HJ, Kwon HC, Kim SH, Kim JS, Lee JH, Jung GJ, Kim MC. Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine. World J Gastroenterol 2006; 12(4): 603-607
URL: https://www.wjgnet.com/1007-9327/full/v12/i4/603.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i4.603